Stay updated on Pembrolizumab in Recurrent Respiratory Papilloma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Recurrent Respiratory Papilloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Recurrent Respiratory Papilloma Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.5.3 to v3.5.4, indicating a new version of the page was published. This update does not alter the study content or layout beyond the version reference.
    Difference
    0.1%
    Check dated 2026-05-15T04:52:46.000Z thumbnail image
  4. Check
    28 days ago
    No Change Detected
  5. Check
    35 days ago
    Change Detected
    Summary
    The study record now marks the trial as Completed, replacing the prior Active, not recruiting status. The update includes date stamps and a revision tag (v3.5.3), indicating documentation updates associated with completion.
    Difference
    0.6%
    Check dated 2026-04-30T18:53:00.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    Revision note added: Revision: v3.5.2; Revision: v3.5.0 was removed.
    Difference
    0.1%
    Check dated 2026-04-16T10:47:23.000Z thumbnail image
  7. Check
    78 days ago
    Change Detected
    Summary
    Updated the page versioning: added revision v3.5.0 and removed revision v3.4.3. This updates metadata rather than core study content.
    Difference
    0.1%
    Check dated 2026-03-18T17:44:41.000Z thumbnail image
  8. Check
    86 days ago
    Change Detected
    Summary
    Revision: v3.4.3 was added and revision: v3.4.2 was removed.
    Difference
    0.1%
    Check dated 2026-03-11T14:27:14.000Z thumbnail image
  9. Check
    114 days ago
    Change Detected
    Summary
    Revision tag updated to v3.4.2 and the older funding-status notice (v3.4.1) was removed. No changes to study details, eligibility criteria, or navigation were observed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-11T02:27:43.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Recurrent Respiratory Papilloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Recurrent Respiratory Papilloma Clinical Trial page.